Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Energy
- Branch
- Not reported
- Recipient company
- RADIATION MONITORING DEVICES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- SCKQA85YU4U4
- Solicitation number
- DE-PS02-06ER06-30
- Topic code
- 51
Research abstract
With the ever-increasing number of human disease models, particularly models in smaller animals, high-resolution emission/transmission tomography techniques have become extremely important. The barriers to using existing modalities in studies of laboratory animals have traditionally been poor spatial resolution, low sensitivity, and high cost. Although detector technologies have improved significantly in recent years, the current state-of-the-art scintillator technology remains the primary performance-limiting factor. To address these issues, this project will design and develop a novel scintillator coupled to a very high spatial resolution photodetector. Phase I research demonstrated the feasibility of developing a novel scintillator array capable of providing parallax-free, high resolution imaging of high-energy radioisotopes. The Phase II research is a logical extension of the Phase I work, with the focus on improving the throughput of the materials processing technique, fabricating a larger-area focused scintillator array, fabricating a prototype detector, and thoroughly evaluating these devices at our collaborators¿ facilities. Substantial efforts toward commercialization of this technology will also be made. Commercial Applications and other Benefits as described by the awardee: Molecular imaging techniques are well suited for imaging radiolabeled antibodies and other substances used to localize and characterize tumors in small animals, and for developing new radiolabeled agents for diagnosing and treating diseases in humans. This detector will significantly improve the resolution and sensitivity with which measurements can be made, allowing the development of superior drugs and technologies to diagnose and stage certain cancers, diseases of the heart and disorders of the circulatory system, and treatments to curtail the progression and even to cure these conditions. Beyond medical imaging, the detector will have broad application in industrial radiography, nondestructive evaluations, homeland security, and other advanced imaging applications.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
930 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $346,950,619. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Energy, Department of Health and Human Services, Department of Defense, National Aeronautics and Space Administration, National Science Foundation, Department of Homeland Security
Agency intelligence
Department of Energy
Back to SBIR/STTR Research Awards